CD24 and neoplasm: Moreover, we were able to demonstrate differential expression of CD24 in benign vs malignant tumours by immunohistochemistry; however, we could not definitively show significant differential expression of SPARCL1, as significant positive staining was observed in stromal cells from both the benign and malignant tumours.